Home NDC 69784-130 Pyridostigmine Bromide
Product NDC 69784-130
11-digit product format 697840130
Labeler code 69784
Product ID 69784-130_efdfa153-19a5-3efa-e053-2a95a90a1139
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name pyridostigmine bromide
Dosage form SOLUTION
Route ORAL
Labeler Woodward Pharma Services LLC
Application ANDA212405
Marketing category ANDA
Marketing start 2022-12-15
Marketing end 0000-00-00
Substance PYRIDOSTIGMINE BROMIDE
Active strength 60 mg/5mL
Pharmacologic classes Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 20 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 69784-130-01 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 69784-130-01 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 69784-130-01 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 69784-130-01 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 69784-130-01 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 69784-130-01 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 69784-130-01 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 69784-130-01 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 69784-130-01 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 69784-130-01 ad56d346431e…cc804d4bbf1e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A212405-001 PYRIDOSTIGMINE BROMIDE PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A212405-001 AA
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 5c6f7cd8ea54…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL 2022-04-19 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A212405-001 PYRIDOSTIGMINE BROMIDE 60MG/5ML SYRUP / ORAL AA 2022-04-19 a50c72e98297…
Observed Orange Book normalized TE history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 69784-130-01 69784013001 473 mL in 1 BOTTLE (69784-130-01) 473 ml 2019-02-18 0000-00-00 No No Current